premium content
UK Oil & Gas – as we await share consolidation what price the next bailout placing? And where does this leave Dave Lenigas and Pennpetro?
I write as UK Oil & Gas (UKOG) holds aa GM to approve a share consolidation. Like so many penny dreadfuls its shares have collapsed below par value of just 0.01p and it must therefore undertake a capital reorganization slashing par to just 0.0001p to allow it to issue even more worthless confetti. And boy does it need to issue shares.- By Tom Winnifrith |
- 16 February 2024, 11:58 |
Video: Poking Bears And Black Swans
Analyst Dave Kranzler has a number of stark warnings of doom for stockmarket bulls but starts this podcast with a discussion of the Tucker Carlson Vladimir Putin interview, something I shall be covering later in my next Russia/Ukraine podcast.- By Tom Winnifrith |
- 16 February 2024, 11:03 |
premium content
Jubilee Metals – Zambia copper expansion progress, Buy
Jubilee Metals (JLP) has issued an update on its copper expansion in Zambia, including that it “is well on track of achieving its initial target of 25,000 tonnes of copper per annum”.- By Tom Winnifrith & Steve Moore |
- 16 February 2024, 10:19 |
premium content
Letter to the FCA: What is stopping you forcing a statement from the Supply@ME Capital fraud?
Following the collapse in the share price of sister company Dispensa (DISP) following advisor auditor resignations and plans for a delisting, surely even the woke dullards at the FCA must be getting worried about Supply@ME Capital (SYME), another joke admission to the Standard list thanks to the incompetence of er…..the FCA. I have dropped it a note regarding a January 31 deadline.- By Tom Winnifrith |
- 16 February 2024, 10:08 |
premium content
Mattioli Woods – interims, growth and recovery Buy
Wealth and asset management company Mattioli Woods (MTW) has announced its results for its half-year ended 30th November 2023 and that it is well positioned to take advantage of the growth opportunities in the UK wealth market.- By Tom Winnifrith & Steve Moore |
- 16 February 2024, 09:20 |
premium content
Crossword Cybersecurity – after “trading update” cash position that dare not speak its name, what of a “Partnership” RNS Reach announcement?
Crossword Cybersecurity (CCS) has announced that it is “very pleased” to have finalised an agreement with New York Stock Exchange-listed TD Synnex (NYSE - SNX) and “to amplifying the reach and exposure of Trillion through the distributor's vast network”. So what of currently a share price response to 4.25p, 17.5% lower?- By Steve Moore |
- 15 February 2024, 16:00 |
premium content
Tom Winnifrith Bearcast: Diversified Energy and its share price obsession - another red flag
In today's Bearcast I look at the eminently shortable Diversified Energy (DEC), Premier African Minerals (PREM) run by George (Cock)Roach, the fraud Supply@ME Capital (SYME), Close Brothers (CBG), BlueJay (JAY), Skinbiotherapeutics (SBTX), and BSF Enterprises (BSFA) - discounted placing ahoy!- By Tom Winnifrith |
- 15 February 2024, 15:10 |
premium content
Is Stuart Ashman lying again?
My real beef with Stuart Ashman, the CEO of Skinbiotherapeutics (SBTX) is not his grotesque pay package and the fact that he snaffled a pay rise last year when his company headed backwards operationally. Nor is it that he tells overt porkies with his “Rules are rules” claims. My real gripe is, as explained in bearcast today, how poor decisions made by him have cost we loyal shareholders badly. Losing 2/3 of the share price in less than three months is worse than careless. But back to the lying.- By Tom Winnifrith |
- 15 February 2024, 14:29 |
premium content
DSW Capital – from late-November “activity levels continuing to improve” to “the improving trend… has stalled” already!
Describing itself, quite unspecifically, as “a profitable, mid-market, challenger professional services licence network and owner of the Dow Schofield Watts brand”, DSW Capital (DSW) has issued a “trading update” including that it “now anticipate FY 24 adjusted pre-tax profit to be in the range of £0.6m to £0.7m… cash balance of £2.7m at 31 January 2024”. What of those and the outlook compared to a currently more than 17% lower share price in response at 50p?- By Steve Moore |
- 15 February 2024, 13:45 |
premium content
Toxic Dave Sefton suffers yet another business blow up
Shareholders in Iconic Labs (ICON) and Anglo African Oil & Gas (AAOG) both suffered massive losses due to the poor management of their respective business by Toxic David Sefton. I can report that Toxic Dave’s reverse Midas touch remains.- By Tom Winnifrith |
- 15 February 2024, 12:21 |
premium content
The UK is in recession – three points you may not have twigged made by an economics nerd
The headlines today are clear. Two successive quarters of GDP shrinkage means that the UK is officially in recession. Cue all sorts of comments which usually say more about those making the comments than about what is going on. Let’s start with Brexit.- By Tom Winnifrith |
- 15 February 2024, 12:02 |
premium content
Gattaca – “pleased to report… trading in line with current market expectations”. Er, is it though?…
Shares in specialist 'STEM' skillsets staffing company Gattaca (GATC) most recently closed at 125p and today a trading update in which CEO Matthew Wragg is “pleased to report the group is trading in line with current market expectations” and that a “strategy to invest in business development is starting to bear fruit, with two large client extensions and two more Managed Service Provider wins for the group in H1 and a growing pipeline”. So what of a currently down towards 110p share price?- By Steve Moore |
- 15 February 2024, 11:19 |
premium content
Oxford Cannabinoid completes January 30 fundraise – now it needs another one to avoid insolvency by July (or earlier)
The fragrant Warwick University philosophy student who is running Oxford Cannabinoid (OCTP) into the ground, Ms. Clarissa Sowemimo-Coker is delighted to announce that the subscription element of the £1.1 million net 0.5p per share fund raise announced on January 30 has now completed. Already the bid is, at 0.47p, below the fundraise price, always a bad sign as the new shares do not start trading until 20 February. But worse is to come.- By Tom Winnifrith |
- 15 February 2024, 10:10 |
premium content
Iconic Labs gets AGM approval to issue billions more shares, will it set a new confetti issuing record in 2024?
Iconic (ICON) successfully passed all its AGM resolutions on 13 February and in each case over 90% of votes were cast in favour of the resolutions but under a third of shareholders bothered to vote.- By Tom Winnifrith |
- 15 February 2024, 10:05 |
premium content
Kefi Gold & Copper – Tulu Kapi update, an upcoming financing and project launch catalysts Strong Buy
Kefi Gold & Copper (KEFI) has issued a “Tulu Kapi Gold Project Update” including the big news that “all the other parties in the funding syndicate, have advised they will this month go to their respective committees to approve the proposed transaction” and that contractors have all reaffirmed to enable full project launch in the current half-year as previously outlined. This very good news has currently helped the shares up approaching 14% at 0.675p to buy, but there looks much more upside to come.- By HotStockRockets |
- 15 February 2024, 08:50 |
premium content
Tom Winnifrith Bearcast: gold dips, bitcoin surges, what is going on?
In today's podcast I discuss: gold, bitcoin, Argo Blockchain (ARB) and why it is still burning cash, FCA failings, statements needed from Chill Brands (CHLL) and Supply@ME Capital (SYME) and the latest shocker from Vast Resources (VAST), Roland "fatty" Cornish and his pal the sex therapist.- By Tom Winnifrith |
- 14 February 2024, 16:50 |
premium content
Verici Dx – equity raise, more to “advance multiple growth initiatives” or fund ongoing cash burn?…
Previously writing on company describing itself as “a developer of advanced clinical diagnostics for organ transplant” Verici Dx (VRCI), in November with the shares up to 9.5p I wrote “Commercialisation agreement with Thermo Fisher”, but still what about that cash burn? – concluding that, with also house broker Singer Capital Markets only talking of the cash runway as a result being extended only to at least the end of 2024, it is still then what? Therefore, at that juncture and a £16.2 million market capitalisation, I continued to avoid. So what of, already, now the company “pleased to announce… gross proceeds of the fundraising amount to £6.50 million”?
- By Steve Moore |
- 14 February 2024, 16:05 |
premium content
Amaroq Minerals – a placing, but a good one! Upgrade stance on a winning tip to Buy
With the largest package of mineral rights in southern Greenland, Amaroq Minerals (AMRQ) announced an equity raise of approximately £30 million “to accelerate development and exploration activities”. However, as suggested by the price of the fundraising despite a depressed market, the prospective accelerated development and exploration looks very exciting indeed.- By Tom Winnifrith & Steve Moore |
- 14 February 2024, 14:15 |
premium content
BREAKING: Roll up to the Vast Resources GM to mix with Fatty Cornish and the Sex Therapist
The Vast Resources (VAST) GM called to approve yet another share consolidation will be held at Nettlestead Place, Maidstone Road, Nettlestead, near Maidstone, a country mansion. Where are the shareholders’ country mansions I hear you ask for this is the residence of fat cat Vast boss Roy Tucker. But he is, as you can see below, not the only resident.- By Tom Winnifrith, the Sheriff of AIM |
- 14 February 2024, 13:54 |
premium content
Allergy Therapeutics – “half-year trading update”, to soon require further funding again!
Previously writing on allergy vaccines company Allergy Therapeutics (AGY), in August with the shares down towards 2.5p I concluded very significant funding to be needed quite swiftly and it not in a good negotiating position. So what of now, with the shares having most recently closed at 2.45p, an update on its half-year?
- By Steve Moore |
- 14 February 2024, 13:39 |